2008-08-01 02:43:00 -

www.windhover.com/in3east08 - Medtech Insight A division of FDC/Windhover and Reed Elsevier Kristy Grimes, 480-985-9512 or 888-202-5939 toll-free in the U.S. kristy@medtechinsight.com Kayleen Kell, 949-453-0071, ext. 313 or 888-290-2225 toll-free in the U.S. kayleen@medtechinsight.com www.medtechinsight.com Medtech Insight, a division of FDC/Windhover and Reed Elsevier and a leading provider of business information for the

medical device industry, has announced that its first-of-its-kind "Medical Device Investor Day" symposium on October 22nd in Boston, MA, will feature illuminating presentations by senior executives from approximately 15 of the most influential large companies in the device space, with 8 presenters confirmed to date. The all-day Investor Day event is being held at the Westin Copley Place in Boston, immediately prior to its annual "Investment In Innovation (In3) East" event. The symposium represents an extraordinary opportunity for attendees to learn first-hand what the powerhouses of the device industry are thinking, doing, and planning in terms of investment, as well as partner and network with our audience of key decision-makers from the medical device and healthcare investment industries.

At Investor Day, senior executives from a carefully selected group of the most influential device companies in the industry will speak candidly on what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also inform our audience about partnering opportunities, how companies can maximize their visibility in front of large company investors, and what role M&A plays at their companies. The eight confirmed presenters for Investor Day to date include Susan Paquette, Technology Assessment Director at 3M; Paul O'Connell, Vice President, Vascular Interventional Products Group at B. Braun Medical; Becton Dickinson (BD), Jim Gilbert, Executive Vice President, Strategy and Business Development at Boston Scientific; Dennis Crowley, Director Business Development at Covidien; M. E. Helms, Director, WW New Business Development at Johnson & Johnson Wound Management, a division of Ethicon; Shawn McCormick, Director, Corporate Development at Medtronic; and a key executive from Stryker, among others being added regularly to the program.

David Cassak, Managing Partner at Windhover Information, kicks off this exciting day with an opening keynote address on the state of larger medical technology company M&A and deal trends. He will be discussing which investment models for larger companies are working, how larger companies are sustaining growth and what the current and future appetite is for M&A.

Investor Day attendees will walk away with practical, real-life lessons and advice from some of the most experienced dealmakers in the worldwide medical technology marketplace. The registration rate for Medical Device Investor Day only is $795, or this is discounted to $495 when registering for In3 East at the same time. Full event details are available on the event website, at www.windhover.com/investorday.

Medical Device Investor Day is immediately followed by the company's annual "Investment In Innovation (In3) East" conference, taking place the evening of October 22 through the afternoon of October 24, also at The Westin Copley Place in Boston, MA. More than 30 early- to late-stage device companies seeking investment and/or strategic partnership are confirmed to date to present, with more than 50 companies presenting on the In3 East stage in all (most for the first time). It is a do-not-miss event for those looking to partner, invest and network with the most promising young medical technology companies on course to impact the worldwide med device market, and complements the large company investment and partnering focus of the "Medical Device Investor Day" symposium. Full event details are available at www.windhover.com/in3east08.

Medtech Insight and its parent company, FDC/Windhover and Reed Elsevier, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1400 emerging medical technology company presenters and over 7500 attendees have participated at In3 events over the past 7 years.

Medtech Insight and FDC/Windhover will also hold their "Investment In Innovation (In3) West" conference at The Palazzo in Las Vegas, NV, March 2-4, 2009, followed by "Investment In Innovation (In3) Europe" at the Marriott Rive Gauche Hotel in Paris, April 29-30.

October 22, 2008, Boston, MA